3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia
11
Prostatic Neoplasms
9
Breast Neoplasms
9
Leukemia, Myeloid, Acute
8
Leukemia, Lymphocytic, Chronic, B-Cell
7
Neuroblastoma
6
Myelodysplastic Syndromes
6
Multiple Myeloma
6
Melanoma
6
Lymphoma
6
Glioblastoma
6
Ovarian Neoplasms
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Glioma
4
Osteosarcoma
3
Neoplasm Metastasis
3
Lymphoma, Non-Hodgkin
3
Kidney Neoplasms
3
Fallopian Tube Neoplasms
3
Breast Neoplasms, Male
3
Neoplasms, Plasma Cell
2
Neoplasms
2
Medulloblastoma
2
Hodgkin Disease
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Wilms Tumor
1
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Interventions
fludarabine phosphate
6
Whole-Body Irradiation
5
Melphalan
5
Peripheral Blood Stem Cell Transplantation
4
Mycophenolic Acid
4
Cyclophosphamide
3
thymoglobulin
2
Tacrolimus
2
Methotrexate
2
Cyclosporine
2
Busulfan
2
Antilymphocyte Serum
2
Alemtuzumab
2
merphos
1
fludarabine
1
Thiotepa
1
Stem Cell Transplantation
1
Sirolimus
1
Rituximab
1
Muromonab-CD3
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Cyclosporins
1
Basiliximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hemoglobinuria, Paroxysmal
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
Clear all
No trials found.